Tuesday, September 28, 2004
Ingen Technologies Signs Marketing Contract With Medicore for Secure Balance™ Program
For Release: September 28, 2004
Calimesa, CA – September 28, 2004 - Ingen Technologies, Inc. (OTC: CRTZ) announced today that it has signed a marketing contract with Medicore, Inc.
Medicore, Inc., a dynamic medical marketing organization located in Southern California, has experience in marketing Balance and Fall Prevention programs to physicians throughout the United States, and will provide direct marketing services in selling the Secure Balance™ program to their physician network.
Medicore currently provides balance testing to their physicians, and has agreed to work with the Company in providing vestibular function testing services to physicians who are considering purchasing the Secure Balance™ program. Medicore has sold several of the Company’s products, and has instituted a nationwide marketing program.
Inga Gefter, President of Medicore said, “We have one of the most experienced team of marketing professionals who are knowledgeable in the industry of Balance and Fall Prevention. We look forward to marketing the Secure Balance™ program for Ingen Technologies to our vast physician network.”
The successful Secure Balance™ program is an equipment, training and educational support system available to physicians throughout the United States. Over the past twelve months, the Secure Balance™ system generated approximately $1 million in revenues for Ingen and is now being aggressively marketed throughout the U.S. More recently, the company’s sales have increased in proportion to the expansion of the Company’s marketing network. Its’ marketing strength is based upon superior products and an experienced professional team.
The Secure Balance™ program offers the most sophisticated clinical products for vestibular function testing and balance therapy compared to any of their competitors. “We offer the most medically accepted, comprehensive product line for vestibular function testing at prices lower than our competition,” said Scott Sand, CEO of Ingen Technologies.
More than two million people visit their doctor each year complaining of dizziness or vertigo and the Secure Balance ™ program can substantially help patients and decrease the number of fall related injuries. The elderly population is expected to double over the next decade and comprise the majority of balance disorder patients.
About Medicore, Inc.
Medicore, Inc. has been providing vestibular function testing and balance therapy to physicians throughout the United States. Last year they had started purchasing products from Ingen Technologies and placing the equipment within physician offices, and hospitals.
About Ingen Technologies
Ingen Technologies is a growth-oriented technology company that offers a diverse and progressive service and product line. The Company’s flagship product is its BAFI ™ product, the world’s first, wireless digital low gas warning system for pressurized gas cylinders. BAFI, now in its second generation, is an accurate and cost-effective, real-time pressurized gas warning system that will alert users when gas levels are approaching empty.
The BAFI line has multiple applications in the medical sector, safety and protection (fire and police), aircraft, recreation vehicle and outdoor uses, as well as home and residential, construction and military. BAFI is a patented product that meets or exceeds regulatory compliance of this time of product and is completed and in production.
For more information, visit: www.otcfn.com/crtz .
Investor Relations Contact: Scott R. Sand, C.E.O & Chairman
Ingen Technologies, Inc.
285 E. County Line Road
Calimesa, CA 92320
Rick McCaffrey, Investor Relations
OTC Financial Network
SafeHarbor for Forward-Looking Statements: This news release includes forward-looking statements that are made pursuant to “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.
Download this article in PDF format: CRTZMedicore092704d2.pdf